A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown imp...
Enregistré dans:
Auteurs principaux: | Torben Knuschke, Sebastian Kollenda, Christina Wenzek, Gennadiy Zelinskyy, Philine Steinbach, Ulf Dittmer, Jan Buer, Matthias Epple, Astrid M. Westendorf |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a05 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth
par: Johanna C. Klein, et autres
Publié: (2017) -
Interferon-alpha subtype 11 activates NK cells and enables control of retroviral infection.
par: Kathrin Gibbert, et autres
Publié: (2012) -
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
par: David H. Peng, et autres
Publié: (2020) -
Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation
par: Alexander Roberts, et autres
Publié: (2021) -
Metabolic requirements of NK cells during the acute response against retroviral infection
par: Elisabeth Littwitz-Salomon, et autres
Publié: (2021)